nodes	percent_of_prediction	percent_of_DWPC	metapath
Floxuridine—TYMS—Methotrexate—testicular cancer	0.621	1	CbGbCtD
Floxuridine—TYMS—Vinorelbine—Vinblastine—testicular cancer	0.00385	0.35	CbGdCrCtD
Floxuridine—TYMS—Podofilox—Etoposide—testicular cancer	0.00385	0.35	CbGdCrCtD
Floxuridine—TYMP—seminal vesicle—testicular cancer	0.0033	0.228	CbGeAlD
Floxuridine—TYMS—Vincristine—Vinblastine—testicular cancer	0.00329	0.299	CbGdCrCtD
Floxuridine—TYMS—gonad—testicular cancer	0.00205	0.142	CbGeAlD
Floxuridine—TYMP—female gonad—testicular cancer	0.00194	0.134	CbGeAlD
Floxuridine—TYMP—testis—testicular cancer	0.00172	0.119	CbGeAlD
Floxuridine—TYMS—female gonad—testicular cancer	0.00166	0.115	CbGeAlD
Floxuridine—TYMS—testis—testicular cancer	0.00148	0.102	CbGeAlD
Floxuridine—TYMP—lymph node—testicular cancer	0.00125	0.0862	CbGeAlD
Floxuridine—TYMS—lymph node—testicular cancer	0.00107	0.0739	CbGeAlD
Floxuridine—Glossitis—Doxorubicin—testicular cancer	0.00103	0.00292	CcSEcCtD
Floxuridine—Feeling abnormal—Chlorambucil—testicular cancer	0.00103	0.00292	CcSEcCtD
Floxuridine—Alopecia—Ifosfamide—testicular cancer	0.00103	0.00292	CcSEcCtD
Floxuridine—Ill-defined disorder—Dactinomycin—testicular cancer	0.00103	0.00291	CcSEcCtD
Floxuridine—Gastrointestinal pain—Chlorambucil—testicular cancer	0.00103	0.0029	CcSEcCtD
Floxuridine—Anaemia—Dactinomycin—testicular cancer	0.00103	0.0029	CcSEcCtD
Floxuridine—Erythema—Ifosfamide—testicular cancer	0.00102	0.00287	CcSEcCtD
Floxuridine—Stomatitis—Etoposide—testicular cancer	0.001	0.00283	CcSEcCtD
Floxuridine—Discomfort—Bleomycin—testicular cancer	0.001	0.00283	CcSEcCtD
Floxuridine—Malaise—Dactinomycin—testicular cancer	0.001	0.00283	CcSEcCtD
Floxuridine—Decreased appetite—Vinblastine—testicular cancer	0.000999	0.00283	CcSEcCtD
Floxuridine—Leukopenia—Dactinomycin—testicular cancer	0.000993	0.00281	CcSEcCtD
Floxuridine—Abdominal pain—Chlorambucil—testicular cancer	0.000992	0.0028	CcSEcCtD
Floxuridine—Body temperature increased—Chlorambucil—testicular cancer	0.000992	0.0028	CcSEcCtD
Floxuridine—Confusional state—Bleomycin—testicular cancer	0.000979	0.00277	CcSEcCtD
Floxuridine—Anaphylactic shock—Bleomycin—testicular cancer	0.000971	0.00275	CcSEcCtD
Floxuridine—Infection—Bleomycin—testicular cancer	0.000965	0.00273	CcSEcCtD
Floxuridine—Agranulocytosis—Etoposide—testicular cancer	0.000959	0.00271	CcSEcCtD
Floxuridine—Thrombocytopenia—Bleomycin—testicular cancer	0.000951	0.00269	CcSEcCtD
Floxuridine—Feeling abnormal—Vinblastine—testicular cancer	0.000947	0.00268	CcSEcCtD
Floxuridine—Ill-defined disorder—Ifosfamide—testicular cancer	0.000943	0.00267	CcSEcCtD
Floxuridine—Gastrointestinal pain—Vinblastine—testicular cancer	0.00094	0.00266	CcSEcCtD
Floxuridine—Anaemia—Ifosfamide—testicular cancer	0.00094	0.00266	CcSEcCtD
Floxuridine—Rash maculo-papular—Epirubicin—testicular cancer	0.000936	0.00265	CcSEcCtD
Floxuridine—Discomfort—Dactinomycin—testicular cancer	0.000933	0.00264	CcSEcCtD
Floxuridine—Anorexia—Bleomycin—testicular cancer	0.000925	0.00262	CcSEcCtD
Floxuridine—Hypersensitivity—Chlorambucil—testicular cancer	0.000924	0.00261	CcSEcCtD
Floxuridine—Thrombophlebitis—Methotrexate—testicular cancer	0.000923	0.00261	CcSEcCtD
Floxuridine—Malaise—Ifosfamide—testicular cancer	0.000917	0.00259	CcSEcCtD
Floxuridine—Leukopenia—Ifosfamide—testicular cancer	0.00091	0.00257	CcSEcCtD
Floxuridine—Photosensitivity—Methotrexate—testicular cancer	0.00091	0.00257	CcSEcCtD
Floxuridine—Abdominal pain—Vinblastine—testicular cancer	0.000909	0.00257	CcSEcCtD
Floxuridine—Asthenia—Chlorambucil—testicular cancer	0.0009	0.00254	CcSEcCtD
Floxuridine—Infection—Dactinomycin—testicular cancer	0.0009	0.00254	CcSEcCtD
Floxuridine—Alopecia—Cisplatin—testicular cancer	0.00089	0.00252	CcSEcCtD
Floxuridine—Thrombocytopenia—Dactinomycin—testicular cancer	0.000887	0.00251	CcSEcCtD
Floxuridine—Erythema—Cisplatin—testicular cancer	0.000876	0.00248	CcSEcCtD
Floxuridine—Rash maculo-papular—Doxorubicin—testicular cancer	0.000866	0.00245	CcSEcCtD
Floxuridine—Thrombophlebitis—Epirubicin—testicular cancer	0.000863	0.00244	CcSEcCtD
Floxuridine—Anorexia—Dactinomycin—testicular cancer	0.000863	0.00244	CcSEcCtD
Floxuridine—Diarrhoea—Chlorambucil—testicular cancer	0.000858	0.00243	CcSEcCtD
Floxuridine—Discomfort—Ifosfamide—testicular cancer	0.000855	0.00242	CcSEcCtD
Floxuridine—Photosensitivity—Epirubicin—testicular cancer	0.000851	0.00241	CcSEcCtD
Floxuridine—Hypersensitivity—Vinblastine—testicular cancer	0.000847	0.00239	CcSEcCtD
Floxuridine—Decreased appetite—Bleomycin—testicular cancer	0.000844	0.00239	CcSEcCtD
Floxuridine—Muscle spasms—Cisplatin—testicular cancer	0.000843	0.00238	CcSEcCtD
Floxuridine—Confusional state—Ifosfamide—testicular cancer	0.000837	0.00237	CcSEcCtD
Floxuridine—Anaphylactic shock—Ifosfamide—testicular cancer	0.00083	0.00235	CcSEcCtD
Floxuridine—Asthenia—Vinblastine—testicular cancer	0.000825	0.00233	CcSEcCtD
Floxuridine—Infection—Ifosfamide—testicular cancer	0.000824	0.00233	CcSEcCtD
Floxuridine—Alopecia—Etoposide—testicular cancer	0.000815	0.0023	CcSEcCtD
Floxuridine—Lethargy—Methotrexate—testicular cancer	0.000815	0.0023	CcSEcCtD
Floxuridine—Nervous system disorder—Ifosfamide—testicular cancer	0.000814	0.0023	CcSEcCtD
Floxuridine—Ill-defined disorder—Cisplatin—testicular cancer	0.000813	0.0023	CcSEcCtD
Floxuridine—Thrombocytopenia—Ifosfamide—testicular cancer	0.000812	0.0023	CcSEcCtD
Floxuridine—Anaemia—Cisplatin—testicular cancer	0.00081	0.00229	CcSEcCtD
Floxuridine—Feeling abnormal—Bleomycin—testicular cancer	0.0008	0.00226	CcSEcCtD
Floxuridine—Thrombophlebitis—Doxorubicin—testicular cancer	0.000799	0.00226	CcSEcCtD
Floxuridine—Vomiting—Chlorambucil—testicular cancer	0.000798	0.00226	CcSEcCtD
Floxuridine—Anorexia—Ifosfamide—testicular cancer	0.000791	0.00224	CcSEcCtD
Floxuridine—Malaise—Cisplatin—testicular cancer	0.00079	0.00223	CcSEcCtD
Floxuridine—Photosensitivity—Doxorubicin—testicular cancer	0.000788	0.00223	CcSEcCtD
Floxuridine—Decreased appetite—Dactinomycin—testicular cancer	0.000787	0.00223	CcSEcCtD
Floxuridine—Diarrhoea—Vinblastine—testicular cancer	0.000787	0.00222	CcSEcCtD
Floxuridine—Leukopenia—Cisplatin—testicular cancer	0.000785	0.00222	CcSEcCtD
Floxuridine—Muscle spasms—Etoposide—testicular cancer	0.000772	0.00218	CcSEcCtD
Floxuridine—Body temperature increased—Bleomycin—testicular cancer	0.000767	0.00217	CcSEcCtD
Floxuridine—Lethargy—Epirubicin—testicular cancer	0.000763	0.00216	CcSEcCtD
Floxuridine—Feeling abnormal—Dactinomycin—testicular cancer	0.000746	0.00211	CcSEcCtD
Floxuridine—Nausea—Chlorambucil—testicular cancer	0.000745	0.00211	CcSEcCtD
Floxuridine—Ill-defined disorder—Etoposide—testicular cancer	0.000745	0.00211	CcSEcCtD
Floxuridine—Anaemia—Etoposide—testicular cancer	0.000742	0.0021	CcSEcCtD
Floxuridine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00074	0.00209	CcSEcCtD
Floxuridine—Discomfort—Cisplatin—testicular cancer	0.000737	0.00208	CcSEcCtD
Floxuridine—Vomiting—Vinblastine—testicular cancer	0.000731	0.00207	CcSEcCtD
Floxuridine—Malaise—Etoposide—testicular cancer	0.000724	0.00205	CcSEcCtD
Floxuridine—Decreased appetite—Ifosfamide—testicular cancer	0.000721	0.00204	CcSEcCtD
Floxuridine—Headache—Vinblastine—testicular cancer	0.00072	0.00204	CcSEcCtD
Floxuridine—Leukopenia—Etoposide—testicular cancer	0.000719	0.00203	CcSEcCtD
Floxuridine—Abdominal pain—Dactinomycin—testicular cancer	0.000716	0.00202	CcSEcCtD
Floxuridine—Body temperature increased—Dactinomycin—testicular cancer	0.000716	0.00202	CcSEcCtD
Floxuridine—Anaphylactic shock—Cisplatin—testicular cancer	0.000715	0.00202	CcSEcCtD
Floxuridine—Hypersensitivity—Bleomycin—testicular cancer	0.000715	0.00202	CcSEcCtD
Floxuridine—Infection—Cisplatin—testicular cancer	0.000711	0.00201	CcSEcCtD
Floxuridine—Lethargy—Doxorubicin—testicular cancer	0.000706	0.002	CcSEcCtD
Floxuridine—Nervous system disorder—Cisplatin—testicular cancer	0.000702	0.00198	CcSEcCtD
Floxuridine—Thrombocytopenia—Cisplatin—testicular cancer	0.0007	0.00198	CcSEcCtD
Floxuridine—Asthenia—Bleomycin—testicular cancer	0.000697	0.00197	CcSEcCtD
Floxuridine—Dry skin—Epirubicin—testicular cancer	0.000685	0.00194	CcSEcCtD
Floxuridine—Feeling abnormal—Ifosfamide—testicular cancer	0.000684	0.00193	CcSEcCtD
Floxuridine—Nausea—Vinblastine—testicular cancer	0.000683	0.00193	CcSEcCtD
Floxuridine—Anorexia—Cisplatin—testicular cancer	0.000682	0.00193	CcSEcCtD
Floxuridine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000678	0.00192	CcSEcCtD
Floxuridine—Discomfort—Etoposide—testicular cancer	0.000675	0.00191	CcSEcCtD
Floxuridine—Hypersensitivity—Dactinomycin—testicular cancer	0.000667	0.00189	CcSEcCtD
Floxuridine—Gastritis—Epirubicin—testicular cancer	0.000661	0.00187	CcSEcCtD
Floxuridine—Confusional state—Etoposide—testicular cancer	0.000661	0.00187	CcSEcCtD
Floxuridine—Abdominal pain—Ifosfamide—testicular cancer	0.000656	0.00185	CcSEcCtD
Floxuridine—Body temperature increased—Ifosfamide—testicular cancer	0.000656	0.00185	CcSEcCtD
Floxuridine—Pancytopenia—Methotrexate—testicular cancer	0.000656	0.00185	CcSEcCtD
Floxuridine—Anaphylactic shock—Etoposide—testicular cancer	0.000655	0.00185	CcSEcCtD
Floxuridine—Infection—Etoposide—testicular cancer	0.000651	0.00184	CcSEcCtD
Floxuridine—Asthenia—Dactinomycin—testicular cancer	0.00065	0.00184	CcSEcCtD
Floxuridine—Thrombocytopenia—Etoposide—testicular cancer	0.000642	0.00181	CcSEcCtD
Floxuridine—Dry skin—Doxorubicin—testicular cancer	0.000634	0.00179	CcSEcCtD
Floxuridine—Photosensitivity reaction—Methotrexate—testicular cancer	0.00063	0.00178	CcSEcCtD
Floxuridine—Angina pectoris—Epirubicin—testicular cancer	0.000629	0.00178	CcSEcCtD
Floxuridine—Anorexia—Etoposide—testicular cancer	0.000625	0.00177	CcSEcCtD
Floxuridine—Decreased appetite—Cisplatin—testicular cancer	0.000622	0.00176	CcSEcCtD
Floxuridine—Diarrhoea—Dactinomycin—testicular cancer	0.00062	0.00175	CcSEcCtD
Floxuridine—Vomiting—Bleomycin—testicular cancer	0.000617	0.00175	CcSEcCtD
Floxuridine—Pancytopenia—Epirubicin—testicular cancer	0.000613	0.00173	CcSEcCtD
Floxuridine—Rash—Bleomycin—testicular cancer	0.000612	0.00173	CcSEcCtD
Floxuridine—Gastritis—Doxorubicin—testicular cancer	0.000612	0.00173	CcSEcCtD
Floxuridine—Dermatitis—Bleomycin—testicular cancer	0.000612	0.00173	CcSEcCtD
Floxuridine—Hypersensitivity—Ifosfamide—testicular cancer	0.000611	0.00173	CcSEcCtD
Floxuridine—Stomatitis—Methotrexate—testicular cancer	0.0006	0.0017	CcSEcCtD
Floxuridine—Asthenia—Ifosfamide—testicular cancer	0.000595	0.00168	CcSEcCtD
Floxuridine—Photosensitivity reaction—Epirubicin—testicular cancer	0.00059	0.00167	CcSEcCtD
Floxuridine—Feeling abnormal—Cisplatin—testicular cancer	0.000589	0.00167	CcSEcCtD
Floxuridine—Angina pectoris—Doxorubicin—testicular cancer	0.000582	0.00165	CcSEcCtD
Floxuridine—Epistaxis—Methotrexate—testicular cancer	0.000581	0.00164	CcSEcCtD
Floxuridine—Nausea—Bleomycin—testicular cancer	0.000577	0.00163	CcSEcCtD
Floxuridine—Vomiting—Dactinomycin—testicular cancer	0.000576	0.00163	CcSEcCtD
Floxuridine—Agranulocytosis—Methotrexate—testicular cancer	0.000574	0.00162	CcSEcCtD
Floxuridine—Rash—Dactinomycin—testicular cancer	0.000571	0.00161	CcSEcCtD
Floxuridine—Decreased appetite—Etoposide—testicular cancer	0.00057	0.00161	CcSEcCtD
Floxuridine—Diarrhoea—Ifosfamide—testicular cancer	0.000568	0.00161	CcSEcCtD
Floxuridine—Pancytopenia—Doxorubicin—testicular cancer	0.000568	0.0016	CcSEcCtD
Floxuridine—Body temperature increased—Cisplatin—testicular cancer	0.000565	0.0016	CcSEcCtD
Floxuridine—Stomatitis—Epirubicin—testicular cancer	0.000561	0.00159	CcSEcCtD
Floxuridine—Haemoglobin—Methotrexate—testicular cancer	0.000555	0.00157	CcSEcCtD
Floxuridine—Haemorrhage—Methotrexate—testicular cancer	0.000553	0.00156	CcSEcCtD
Floxuridine—Pharyngitis—Methotrexate—testicular cancer	0.000548	0.00155	CcSEcCtD
Floxuridine—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000546	0.00154	CcSEcCtD
Floxuridine—Epistaxis—Epirubicin—testicular cancer	0.000543	0.00154	CcSEcCtD
Floxuridine—Feeling abnormal—Etoposide—testicular cancer	0.00054	0.00153	CcSEcCtD
Floxuridine—Nausea—Dactinomycin—testicular cancer	0.000538	0.00152	CcSEcCtD
Floxuridine—Agranulocytosis—Epirubicin—testicular cancer	0.000538	0.00152	CcSEcCtD
Floxuridine—Gastrointestinal pain—Etoposide—testicular cancer	0.000536	0.00152	CcSEcCtD
Floxuridine—Vomiting—Ifosfamide—testicular cancer	0.000528	0.00149	CcSEcCtD
Floxuridine—Hypersensitivity—Cisplatin—testicular cancer	0.000527	0.00149	CcSEcCtD
Floxuridine—Rash—Ifosfamide—testicular cancer	0.000523	0.00148	CcSEcCtD
Floxuridine—Dermatitis—Ifosfamide—testicular cancer	0.000523	0.00148	CcSEcCtD
Floxuridine—Haemoglobin—Epirubicin—testicular cancer	0.00052	0.00147	CcSEcCtD
Floxuridine—Stomatitis—Doxorubicin—testicular cancer	0.000519	0.00147	CcSEcCtD
Floxuridine—Body temperature increased—Etoposide—testicular cancer	0.000518	0.00146	CcSEcCtD
Floxuridine—Abdominal pain—Etoposide—testicular cancer	0.000518	0.00146	CcSEcCtD
Floxuridine—Haemorrhage—Epirubicin—testicular cancer	0.000517	0.00146	CcSEcCtD
Floxuridine—Asthenia—Cisplatin—testicular cancer	0.000513	0.00145	CcSEcCtD
Floxuridine—Pharyngitis—Epirubicin—testicular cancer	0.000513	0.00145	CcSEcCtD
Floxuridine—Epistaxis—Doxorubicin—testicular cancer	0.000503	0.00142	CcSEcCtD
Floxuridine—Agranulocytosis—Doxorubicin—testicular cancer	0.000497	0.00141	CcSEcCtD
Floxuridine—Nausea—Ifosfamide—testicular cancer	0.000493	0.00139	CcSEcCtD
Floxuridine—Diarrhoea—Cisplatin—testicular cancer	0.000489	0.00138	CcSEcCtD
Floxuridine—Alopecia—Methotrexate—testicular cancer	0.000488	0.00138	CcSEcCtD
Floxuridine—Hypersensitivity—Etoposide—testicular cancer	0.000483	0.00137	CcSEcCtD
Floxuridine—Erythema—Methotrexate—testicular cancer	0.000481	0.00136	CcSEcCtD
Floxuridine—Haemoglobin—Doxorubicin—testicular cancer	0.000481	0.00136	CcSEcCtD
Floxuridine—Haemorrhage—Doxorubicin—testicular cancer	0.000478	0.00135	CcSEcCtD
Floxuridine—Pharyngitis—Doxorubicin—testicular cancer	0.000475	0.00134	CcSEcCtD
Floxuridine—Asthenia—Etoposide—testicular cancer	0.00047	0.00133	CcSEcCtD
Floxuridine—Alopecia—Epirubicin—testicular cancer	0.000457	0.00129	CcSEcCtD
Floxuridine—Vomiting—Cisplatin—testicular cancer	0.000455	0.00129	CcSEcCtD
Floxuridine—Rash—Cisplatin—testicular cancer	0.000451	0.00128	CcSEcCtD
Floxuridine—Dermatitis—Cisplatin—testicular cancer	0.000451	0.00127	CcSEcCtD
Floxuridine—Erythema—Epirubicin—testicular cancer	0.00045	0.00127	CcSEcCtD
Floxuridine—Diarrhoea—Etoposide—testicular cancer	0.000448	0.00127	CcSEcCtD
Floxuridine—Ill-defined disorder—Methotrexate—testicular cancer	0.000446	0.00126	CcSEcCtD
Floxuridine—Anaemia—Methotrexate—testicular cancer	0.000445	0.00126	CcSEcCtD
Floxuridine—Malaise—Methotrexate—testicular cancer	0.000434	0.00123	CcSEcCtD
Floxuridine—Muscle spasms—Epirubicin—testicular cancer	0.000433	0.00122	CcSEcCtD
Floxuridine—Leukopenia—Methotrexate—testicular cancer	0.000431	0.00122	CcSEcCtD
Floxuridine—Nausea—Cisplatin—testicular cancer	0.000425	0.0012	CcSEcCtD
Floxuridine—Alopecia—Doxorubicin—testicular cancer	0.000423	0.0012	CcSEcCtD
Floxuridine—Ill-defined disorder—Epirubicin—testicular cancer	0.000418	0.00118	CcSEcCtD
Floxuridine—Vomiting—Etoposide—testicular cancer	0.000417	0.00118	CcSEcCtD
Floxuridine—Erythema—Doxorubicin—testicular cancer	0.000416	0.00118	CcSEcCtD
Floxuridine—Anaemia—Epirubicin—testicular cancer	0.000416	0.00118	CcSEcCtD
Floxuridine—Rash—Etoposide—testicular cancer	0.000413	0.00117	CcSEcCtD
Floxuridine—Dermatitis—Etoposide—testicular cancer	0.000413	0.00117	CcSEcCtD
Floxuridine—Headache—Etoposide—testicular cancer	0.000411	0.00116	CcSEcCtD
Floxuridine—Malaise—Epirubicin—testicular cancer	0.000406	0.00115	CcSEcCtD
Floxuridine—Discomfort—Methotrexate—testicular cancer	0.000405	0.00114	CcSEcCtD
Floxuridine—Leukopenia—Epirubicin—testicular cancer	0.000403	0.00114	CcSEcCtD
Floxuridine—Muscle spasms—Doxorubicin—testicular cancer	0.0004	0.00113	CcSEcCtD
Floxuridine—Confusional state—Methotrexate—testicular cancer	0.000396	0.00112	CcSEcCtD
Floxuridine—Anaphylactic shock—Methotrexate—testicular cancer	0.000393	0.00111	CcSEcCtD
Floxuridine—Infection—Methotrexate—testicular cancer	0.00039	0.0011	CcSEcCtD
Floxuridine—Nausea—Etoposide—testicular cancer	0.000389	0.0011	CcSEcCtD
Floxuridine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000386	0.00109	CcSEcCtD
Floxuridine—Nervous system disorder—Methotrexate—testicular cancer	0.000385	0.00109	CcSEcCtD
Floxuridine—Anaemia—Doxorubicin—testicular cancer	0.000385	0.00109	CcSEcCtD
Floxuridine—Thrombocytopenia—Methotrexate—testicular cancer	0.000384	0.00109	CcSEcCtD
Floxuridine—Discomfort—Epirubicin—testicular cancer	0.000379	0.00107	CcSEcCtD
Floxuridine—Malaise—Doxorubicin—testicular cancer	0.000376	0.00106	CcSEcCtD
Floxuridine—Anorexia—Methotrexate—testicular cancer	0.000374	0.00106	CcSEcCtD
Floxuridine—Leukopenia—Doxorubicin—testicular cancer	0.000373	0.00105	CcSEcCtD
Floxuridine—Confusional state—Epirubicin—testicular cancer	0.00037	0.00105	CcSEcCtD
Floxuridine—Anaphylactic shock—Epirubicin—testicular cancer	0.000367	0.00104	CcSEcCtD
Floxuridine—Infection—Epirubicin—testicular cancer	0.000365	0.00103	CcSEcCtD
Floxuridine—Nervous system disorder—Epirubicin—testicular cancer	0.00036	0.00102	CcSEcCtD
Floxuridine—Thrombocytopenia—Epirubicin—testicular cancer	0.00036	0.00102	CcSEcCtD
Floxuridine—Discomfort—Doxorubicin—testicular cancer	0.00035	0.000991	CcSEcCtD
Floxuridine—Anorexia—Epirubicin—testicular cancer	0.00035	0.00099	CcSEcCtD
Floxuridine—Confusional state—Doxorubicin—testicular cancer	0.000343	0.000969	CcSEcCtD
Floxuridine—Decreased appetite—Methotrexate—testicular cancer	0.000341	0.000965	CcSEcCtD
Floxuridine—Anaphylactic shock—Doxorubicin—testicular cancer	0.00034	0.000961	CcSEcCtD
Floxuridine—Infection—Doxorubicin—testicular cancer	0.000338	0.000955	CcSEcCtD
Floxuridine—Nervous system disorder—Doxorubicin—testicular cancer	0.000333	0.000942	CcSEcCtD
Floxuridine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000333	0.000941	CcSEcCtD
Floxuridine—Anorexia—Doxorubicin—testicular cancer	0.000324	0.000916	CcSEcCtD
Floxuridine—Feeling abnormal—Methotrexate—testicular cancer	0.000323	0.000915	CcSEcCtD
Floxuridine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000321	0.000908	CcSEcCtD
Floxuridine—Decreased appetite—Epirubicin—testicular cancer	0.000319	0.000903	CcSEcCtD
Floxuridine—Abdominal pain—Methotrexate—testicular cancer	0.00031	0.000877	CcSEcCtD
Floxuridine—Body temperature increased—Methotrexate—testicular cancer	0.00031	0.000877	CcSEcCtD
Floxuridine—Feeling abnormal—Epirubicin—testicular cancer	0.000303	0.000856	CcSEcCtD
Floxuridine—Gastrointestinal pain—Epirubicin—testicular cancer	0.0003	0.000849	CcSEcCtD
Floxuridine—Decreased appetite—Doxorubicin—testicular cancer	0.000295	0.000835	CcSEcCtD
Floxuridine—Body temperature increased—Epirubicin—testicular cancer	0.00029	0.000821	CcSEcCtD
Floxuridine—Abdominal pain—Epirubicin—testicular cancer	0.00029	0.000821	CcSEcCtD
Floxuridine—Hypersensitivity—Methotrexate—testicular cancer	0.000289	0.000818	CcSEcCtD
Floxuridine—Asthenia—Methotrexate—testicular cancer	0.000282	0.000796	CcSEcCtD
Floxuridine—Feeling abnormal—Doxorubicin—testicular cancer	0.00028	0.000792	CcSEcCtD
Floxuridine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000278	0.000786	CcSEcCtD
Floxuridine—Hypersensitivity—Epirubicin—testicular cancer	0.000271	0.000765	CcSEcCtD
Floxuridine—Abdominal pain—Doxorubicin—testicular cancer	0.000269	0.00076	CcSEcCtD
Floxuridine—Body temperature increased—Doxorubicin—testicular cancer	0.000269	0.00076	CcSEcCtD
Floxuridine—Diarrhoea—Methotrexate—testicular cancer	0.000269	0.000759	CcSEcCtD
Floxuridine—Asthenia—Epirubicin—testicular cancer	0.000264	0.000745	CcSEcCtD
Floxuridine—Diarrhoea—Epirubicin—testicular cancer	0.000251	0.000711	CcSEcCtD
Floxuridine—Hypersensitivity—Doxorubicin—testicular cancer	0.00025	0.000708	CcSEcCtD
Floxuridine—Vomiting—Methotrexate—testicular cancer	0.00025	0.000706	CcSEcCtD
Floxuridine—Rash—Methotrexate—testicular cancer	0.000247	0.0007	CcSEcCtD
Floxuridine—Dermatitis—Methotrexate—testicular cancer	0.000247	0.000699	CcSEcCtD
Floxuridine—Headache—Methotrexate—testicular cancer	0.000246	0.000695	CcSEcCtD
Floxuridine—Asthenia—Doxorubicin—testicular cancer	0.000244	0.00069	CcSEcCtD
Floxuridine—Vomiting—Epirubicin—testicular cancer	0.000234	0.00066	CcSEcCtD
Floxuridine—Nausea—Methotrexate—testicular cancer	0.000233	0.000659	CcSEcCtD
Floxuridine—Diarrhoea—Doxorubicin—testicular cancer	0.000233	0.000658	CcSEcCtD
Floxuridine—Rash—Epirubicin—testicular cancer	0.000232	0.000655	CcSEcCtD
Floxuridine—Dermatitis—Epirubicin—testicular cancer	0.000231	0.000654	CcSEcCtD
Floxuridine—Headache—Epirubicin—testicular cancer	0.00023	0.000651	CcSEcCtD
Floxuridine—Nausea—Epirubicin—testicular cancer	0.000218	0.000617	CcSEcCtD
Floxuridine—Vomiting—Doxorubicin—testicular cancer	0.000216	0.000611	CcSEcCtD
Floxuridine—Rash—Doxorubicin—testicular cancer	0.000214	0.000606	CcSEcCtD
Floxuridine—Dermatitis—Doxorubicin—testicular cancer	0.000214	0.000605	CcSEcCtD
Floxuridine—Headache—Doxorubicin—testicular cancer	0.000213	0.000602	CcSEcCtD
Floxuridine—Nausea—Doxorubicin—testicular cancer	0.000202	0.000571	CcSEcCtD
